Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chinese Herbal Medicine as Adjunct Therapy for Parkinson's Disease
NCT05001217Phase 3Completed
- Sponsor
- Hong Kong Baptist University
- Start
- Jan 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Elix Cycle Balance in Parkinson's disease (PD) (2 arms), sponsored by Hong Kong Baptist University. Primary endpoint: Movement Disorder Society Sponsored Revision of Unified Parkinson's Disease Rating Scale Part II at 32 weeks. Started Jan 2022; status: completed.
02
Drugs
Elix Cycle Balance
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT05001217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05001217.